RespiDerm® Corporation is a Health Care Technology Company headquartered in Little Rock, Arkansas. Through its novel transdermal drug delivery technology, RespiDerm® offers both commercial and home health care treatment providers and users the opportunity to safely, non-invasively, and effectively apply medical solutions into the body without the pain, the side effects, and practical difficulties commonly known with injection and other invasive transdermal delivery methods. RespiDerm’s® research, development, and commercialization efforts focus on the development of practical applications which enable medical solutions to be safely and conveniently delivered into the skin capillaries, in virtually any setting. RespiDerm® is committed to providing non-invasive and pain-free transdermal delivery solutions to traditional and complementary health care providers and self-care users. RespiDerm® continues with the research and development of innovative and user friendly solutions that bio-mimick natural processes, improving the quality of life and well-being of people around the world. The mission is to determine the best methods for combining the non-toxic health benefits of gaseous solutions with non-invasive transcutaneous-delivery approaches.